The estimated Net Worth of Frederick Munsch is at least $164 mil dollars as of 26 February 2022. Mr Munsch owns over 3,330 units of Bausch Health Companies Inc stock worth over $164,272 and over the last 3 years he sold BHC stock worth over $0.
Mr has made over 1 trades of the Bausch Health Companies Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 3,330 units of BHC stock worth $21,245 on 26 February 2022.
The largest trade he's ever made was exercising 3,330 units of Bausch Health Companies Inc stock on 26 February 2022 worth over $21,245. On average, Mr trades about 833 units every 0 days since 2021. As of 26 February 2022 he still owns at least 25,748 units of Bausch Health Companies Inc stock.
You can see the complete history of Mr Munsch stock trades at the bottom of the page.
Frederick J. Munsch is the Controller & Chief Accounting Officer at Bausch Health Companies Inc.
Mr Munsch is 51, he's been the Controller & Chief Accounting Officer of Bausch Health Companies Inc since . There are 19 older and 3 younger executives at Bausch Health Companies Inc. The oldest executive at Bausch Health Companies Inc is Richard De Schutter, 79, who is the Independent Director.
Frederick's mailing address filed with the SEC is 400 SOMERSET CORPORATE BLVD., , BRIDGEWATER, NJ, 08807.
Over the last 6 years, insiders at Bausch Health Companies Inc have traded over $2,786,244 worth of Bausch Health Companies Inc stock and bought 6,317,686 units worth $110,094,785 . The most active insiders traders include John Paulson, Argeris N Karabelas, eBrett Icahn. On average, Bausch Health Companies Inc executives and independent directors trade stock every 36 days with the average trade being worth of $824,564. The most recent stock trade was executed by Seana Carson on 5 September 2024, trading 13,370 units of BHC stock currently worth $83,028.
bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries.five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: people, quality health care outcomes, customer focus, innovation and efficiency. more information can be found at www.bauschhealth.com.###
Bausch Health Companies Inc executives and other stock owners filed with the SEC include: